ArticleAnnals of surgery2019

Comment on "Interpreting Clinical Benefits of Neoadjuvant Chemoradiation With Gemcitabine Versus Upfront Surgery in Patients With Borderline Resectable Pancreatic Cancer (BRPC)".

Zachary R McCaw et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.